Finding Opportunities in This Mixed Market Action

But I'm managing positions carefully and don't trust the upside momentum very much.
Stocks quotes in this article: QQQ, BABA, MOMO, TTD, HIIQ, MRAM, YTRA, KRO, CVGI

A sluggish start brings in some dip buyers, but breadth is running negative as the Nasdaq 100 ETF (QQQ) big-caps are leading. Retail and biotechnology are bouncing after lagging yesterday, and oil is holding steady. Banks are down and small-caps are underperforming.

It is another example of choppy and inconsistent action. It isn't bad, but it is not particularly easy to trade. Many market players are just treading water as they look ahead to Janet Yellen's testimony tomorrow and the kickoff of earnings season over the next few weeks.

There are some chart patterns working. Alibaba (BABA) for example, is breaking to a new all-time closing high, and some of the other China-related names like Momo (MOMO) are acting well.

Some of my recent Stocks of the Week are acting very well. For example, The Trade Desk (TTD) , which I discussed yesterday as a top play into earnings, is doing very well. Health Innovations (HIIQ) , Everspin (MRAM) and Yatra (YTRA) are all trading up nicely.

A couple of new names I'm watching are Kronos Worldwide (KRO) and Commercial Vehicle Group (CVGI) .

I'm managing positions carefully and don't trust the upside momentum very much, but there are some opportunities in this mixed action.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long BABA, TTD, HIIQ, MRAM, YTRA, KRO and CVGI, although positions may change at any time.

TAGS: Investing | U.S. Equity | Healthcare | Technology | Markets | Risk Management | Stocks

More from Healthcare

Prospective Pickings Are Slim for This Annual Portfolio of Unloved Losers

Jonathan Heller

The current candidates for the 2022 Tax-Loss Selling Recovery Portfolio are few and far between, with only a couple households names in the bunch.

Here's Why Paratek Pharmaceuticals Is the Only Antibiotic Name in My Portfolio

Bret Jensen

The economics of this space is not nearly as favorable as the outcomes these drugs achieve in medical settings.

3 Smaller Healthcare Stocks That Still Look Like Values in a Pricey Market

Bret Jensen

ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.

I'm in the Buy and Hold Category With FIGS

Timothy Collins

FIGS has become the trendy play for scrubs.

A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players

Debra Borchardt

To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight